Home

PB Ratio of Jenburkt Pharmaceuticals Ltd

Image

Jenburkt Pharmaceuticals Ltd

NSE: JENBURKTPHARMA

PB Ratio

2.8

Last updated on: Dec 01, 2025

Key Highlights

  • The latest PB Ratio of Jenburkt Pharmaceuticals Ltd is 2.8.
  • The PB ratio of the Jenburkt Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Jenburkt Pharmaceuticals Ltd changed from 1.8 on March 2020 to 2.6 on March 2025 . This represents a CAGR of 6.32% over 6 years.

Historical P/B Ratio of Jenburkt Pharmaceuticals Ltd

No data available

Company Fundamentals for Jenburkt Pharmaceuticals Ltd

Market Cap

506 Cr

EPS

74.8

P/E Ratio (TTM)

15.3

P/B Ratio (TTM)

2.8

Day’s High

1150.9

Day’s Low

1121.8

DTE

0.0

ROE

18.0

52 Week High

1410.0

52 Week Low

936.7

ROCE

24.7

Market Price of Jenburkt Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jenburkt Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Dec 20251129.6
01 Dec 20251146.65
28 Nov 20251167.75
27 Nov 20251171.85
26 Nov 20251193.15
25 Nov 20251176.2
24 Nov 20251193.5
21 Nov 20251243.2
20 Nov 20251237.2
19 Nov 20251237.05

SWOT Analysis Of Jenburkt Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Jenburkt Pharmaceuticals Ltd

Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PB Ratio of Jenburkt Pharmaceuticals Ltd Explained

506.05

Market cap

414

Book Value per Share

2.8X

PB Ratio

Historical Market Cap of Jenburkt Pharmaceuticals Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Jenburkt Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Jenburkt Pharmaceuticals Ltd News Hub

Jenburkt Pharmaceuticals to announce Quarterly Result

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November

Read more

29 Oct 24

Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2

Read more

05 Nov 24

Jenburkt Pharmaceuticals to hold AGM

Jenburkt Pharmaceuticals announced that the 40th Annual General Meeting(AGM) of the company will be

Read more

21 May 25

Jenburkt Pharmaceuticals to table results

Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January

Read more

21 Jan 25

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Jenburkt Pharmaceuticals Ltd

What is the PB ratio of Jenburkt Pharmaceuticals Ltd?

The current PB ratio of Jenburkt Pharmaceuticals Ltd is 2.77. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Jenburkt Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Jenburkt Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Jenburkt Pharmaceuticals Ltd calculated?

The PB ratio of Jenburkt Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Jenburkt Pharmaceuticals Ltd?

A high PB ratio suggests that Jenburkt Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Jenburkt Pharmaceuticals Ltd?

A low PB ratio of Jenburkt Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Jenburkt Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Jenburkt Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions